{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:12:31Z","timestamp":1759709551984,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Tuberous sclerosis complex (TSC) is a genetic disorder that affects multiple organ systems but often goes unrecognized, and a delay in diagnosis can lead to multiple complications. Healthcare professionals should be educated on the many signs and symptoms associated with the disorder, know how to treat them symptomatically, and recommend routine screening to assess for complications. Correctly identifying, diagnosing, and treating TSC can give patients a better quality of life and prevent further complications associated with the disorder.<\/jats:p>","DOI":"10.1097\/01.jaa.0000733220.26720.62","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T18:51:47Z","timestamp":1612551107000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Tuberous sclerosis complex"],"prefix":"10.1097","volume":"34","author":[{"given":"Kelliann","family":"Notaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000254570","article-title":"Tuberous sclerosis: epidemiology, genetics and progress towards treatment","volume":"33","author":"Morrison","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"9639","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","article-title":"Tuberous sclerosis complex: review based on new diagnostic criteria","volume":"93","author":"Portocarrero","year":"2018","journal-title":"An Bras Dermatol"},{"journal-title":"Harrison's Principles of Internal Medicine","year":"2018","author":"Jameson","key":"R4-20250607"},{"issue":"9","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.braindev.2013.11.003","article-title":"Arachnoid cysts in tuberous sclerosis complex","volume":"36","author":"Boronat","year":"2014","journal-title":"Brain Dev"},{"issue":"4","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"10","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000448293","article-title":"Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: current data and future study","volume":"134","author":"Kingswood","year":"2016","journal-title":"Nephron"},{"issue":"3","key":"R12-20250607","doi-asserted-by":"crossref","first-page":"e0229397","DOI":"10.1371\/journal.pone.0229397","article-title":"Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure","volume":"15","author":"Iwata","year":"2020","journal-title":"PLoS One"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TACG.S90262","article-title":"Genetics of tuberous sclerosis complex: implications for clinical practice","volume":"10","author":"Caban","year":"2016","journal-title":"Appl Clin Genet"},{"issue":"4","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"R17-20250607","first-page":"211","article-title":"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex","volume":"7","author":"Franz","year":"2013","journal-title":"Biologics"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000733220.26720.62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:02:04Z","timestamp":1749322924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000733220.26720.62"}},"subtitle":["A multisystem disorder"],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000733220.26720.62","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}